Given a known function of IL-17A in promoting cellular immune responses, we hypothesized that the intense IL-17A+ cellular infiltration found in TNBC patients might be triggered and/or attributed by tumor-derived IL-17A production. The gene discussed is IL17A; the disease is neoplasm.